目的:探析肺炎采用哌拉西林舒巴坦治疗的临床效果。方法:选择2015年4月-2016年4月期间我院收治的70例肺炎患者为研究对象,随机分为两组,其中给予对照组常规治疗,而观察组则运用哌拉西林舒巴坦治疗,比较分析两组治疗效果。结果:与对照组比较,观察组的治疗有效率高,组间对比差异明显(P<0.05);同时,相比较对照组而言,观察组的不良反应发生率低,但是组间比较无差异(P>0.05)。结论:临床上运用哌拉西林舒巴坦治疗肺炎,不仅疗效显著,还不容易发生不良反应,值得推广。 Objective: To investigate the clinical effect of piperacillin-sulbactam in pneumonia. Methods: Seventy patients with pneumonia admitted in our hospital from April 2015 to April 2016 were selected and randomly divided into two groups, of which the control group received routine treatment, while the observation group received piperacillin-sulbactam , Comparative analysis of two groups of treatment. Results: Compared with the control group, the treatment group had a high effective rate of treatment, with significant difference between the two groups (P <0.05). Meanwhile, the incidence of adverse reactions in the observation group was lower than that in the control group, but there was no difference between the two groups (P> 0.05). Conclusion: The clinical use of piperacillin-sulbactam in the treatment of pneumonia not only has significant curative effect, but also is not prone to adverse reactions and is worth promoting.